Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
biotech
boston blog main
2
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
merck
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
allergan aesthetics
alzheimer's disease
amgen
antibiotics
arvinas
athira pharma
attralus
biontech
boehringer ingelheim
boston
What
way
2
×
week
2
×
acquisitions
biggest
bio
biotechs
build
buy
ceo
chose
close
company
company’s
daniel
debut
device
drug
dyne’s
firms
gilead
ipo
ipos
life
make
medical
microbiome
moves
open
openly
o’day
pipeline
q
quarter
roundup
science
sciences
scores
seagen
spoken
window
Language
unset
Current search:
week
×
" boston blog main "
×
way
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way